Synthesis and Biological Properties of a Biotinylated Derivative of Acth_1-17 for MSH Receptor Studies

References

• Murphy J. R., Bishai W., Borowski M., Miyanohara A., Boyd J., Nagle S. Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related α-melanocyte-stimulating hormone fusion protein. Proc. Natl. Acad. Sci. USA 1986; 83: 8258–8262
   PubMed Web of Science ®Google Scholar
• Bard D. R., Knight C. G., Page-Thomas D. P. A chelating derivative of α-melanocyte-stimulating hormone as a potential imaging agent for malignant melanoma. Br. J. Cancer 1990; 62: 919–922
   PubMed Web of Science ®Google Scholar
• Bagutti C., Stolz B., Albert R., Bruns C., Pless J., Eberle A. N. ¹¹¹In-DTPA-labelled analogues of α-MSH for the detection of MSH receptors in vitro and in vivo, In preparation
   Google Scholar
• Siegrist W., Oestreicher M., Stutz S., Girard J., Eberle A. N. Radioreceptor assay for α-MSH using mouse B16 melanoma cells. J. Receptor Res. 1988; 8: 323–343
   PubMed Web of Science ®Google Scholar
• Siegrist W., Girard J., Eberle A. N. Quantification of MSH receptors on mouse melanoma tissue by receptor autoradio-graphy. J. Receptor Res. 1991; 11: 323–331
   PubMed Web of Science ®Google Scholar
• Tatro J. B., Entwistle M. L., Lester B. R., Reichlin S. Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ. Cancer Res. 1990; 50: 1237–1242
   PubMed Web of Science ®Google Scholar
• Siegrist W., Solca F., Stutz S., Guiffrè L., Carrel S., Girard J., Eberle A. N. Characterization of receptors for α-melanocyte-stimulating hormone on human melanoma cells. Cancer Res. 1989; 49: 6352–6358
   PubMed Web of Science ®Google Scholar
• Ghanem G. E., Communale G., Libert A., Vercammen-Grandjean A., Lejeune F. J. Evidence for alpha-melanocyte-stimulating hormone (a-MSH) receptors on human malignant melanoma cells. Int. J. Cancer 1988; 41: 248–255
   PubMed Web of Science ®Google Scholar
• Tatro J. B., Atkins M., Mier J. W., Hardarson S., Wolfe H., Smith T., Entwistle M. L., Reichlin S. Melanotropin receptors demonstrated in situ in human melanoma. J. Clin. Invest. 1990; 85: 1825–1832
   PubMed Web of Science ®Google Scholar
• Geiger R. Synthese eines Heptadecapeptides mit hoher adreno-corticotroper Wirkung. Liebigs Ann. Chem. 1971; 750: 165–170
   Google Scholar
• Siegrist W., Bagutti C., Eberle A. N. An ACTH fragment analogue, [β-Ala¹ Lys¹⁷]-ACTH_1–17-heptadecapeptide-4-amino-n-butylamide, is a very potent ligand for the human melanoma MSH receptor, In preparation
   Google Scholar
• Avidin-biotin technology. Meth. Enzymol, M. Wilchek, E. A. Bayer, 1990; 184
   Google Scholar
• Childs G. V., Naor Z., Hazum E., Tibolt R., Westlung K. N., Hancock M. B. Localization of biotinylated gonadotropin releasing hormone on pituitary monolayer cells with avidinbiotin-peroxidase complexes. J. Histochem. Cytochem. 1983; 31: 1422–1425
   PubMedGoogle Scholar
• Childs G. V., Morell J. L., Niendorf A., Aguilera G. Cyto-chemical studies of corticotropin-releasing factor (CRF) receptors in anterior lobe corticotropes: binding, glucocorticoid regulation, and endocytosis of [biotinyl-Ser1]-CRF. Endocrinology 1986; 119: 2129–2142
   PubMed Web of Science ®Google Scholar
• Spitzer E., de Los Angeles M., Perez R., Grosse R. Binding properties of biotinylated epidermal growth factor to its receptor on cultured cells and tissue sections. J. Cell. Biochem. 1989; 41: 47–56
   PubMed Web of Science ®Google Scholar
• Abou-Samra A.-B., Freeman M., Jüppner H., Uneno S., Segre G. V. Characterization of fully active biotinylated parathyroid hormone analogs. Application to fluorescence-activated cell sortin of parathyroid hormone receptor bearing cells. J. Biol. Chem. 1990; 265: 58–62
   PubMedGoogle Scholar
• Seyer R., Aumelas A., Tence M., Marie J., Bonnafous J.-C., Jard S., Castro B. Synthesis of a biotinylated, iodinatable, and photoactivatable probe for angiotensin receptors. Int. J. Pept. Protein Res. 1989; 34: 235–245
   PubMedGoogle Scholar
• Paganelli G., Riva P., Deleide G., Clivio A., Chiolerio F., Scassellati G. A., Malcovati M., Siccardi A. G. In vivo labelling of biotinylated monoclonal antibodies by radioactive avidin: a strategy to increase tumor radiolocalization. Int. J. Cancer 1988, suppl. 2: 121–125
   Google Scholar
• Kalofonos H. P., Rusckowski D. A., Siebecker D. A., Sivolapenko G. B., Snook D., Lavender J. P., Epenetos A. A., Hnatowich D. J. Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication. J. Nucl. Med. 1990; 31: 1791–1796
   PubMed Web of Science ®Google Scholar
• Breipohl G., Knolle J., Geiger R. Solid phase synthesis of peptide aminoalkylamides: development and application of new linking agents. Tetrahedron Lett. 1987; 28: 5647–5650
   Google Scholar
• Eberle A. N., Jäggin Verin V., Solca F., Siegrist W., Küenlin C., Bagutti C., Stutz S., Girard J. Biologically active monoiodinated α-MSH derivatives for receptor binding studies using human melanoma cells. J. Receptor Res. 1991; 11: 311–322
   PubMed Web of Science ®Google Scholar
• Siegrist W., Oestreicher M., Stutz S., Girard J., Eberle A. N. Radioreceptor assay for α-MSH using mouse B16 melanoma cells. J. Receptor Res. 1988; 8: 323–343
   PubMed Web of Science ®Google Scholar
• Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 1980; 107: 220–239
   PubMed Web of Science ®Google Scholar
• Siegrist W., Eberle A. N. In situ melanin assay for MSH using mouse B16 melanoma cells in culture. Anal. Biochem. 1986; 159: 191–197
   PubMed Web of Science ®Google Scholar